IP Library › Granted Patent US 10,318,707
Granted Patent B2
US 10,318,707 · App. 14/266,954 · Granted Jun 11, 2019

Multi-parameter thrombotic assay apparatus, systems, and methods

Inventors: Kumaran Kolandaivelu (Newton, MA); Elazer R. Edelman (Brookline, MA)
Assignees: Massachusetts Institute of Technology; The Brigham and Women's Hospital, Inc.
G06F19/26G01N33/4905G01N33/86G01N2800/226
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,318,707
App. No.
14/266,954
Granted
Jun 11, 2019
Kind
B2
Abstract

Apparatus, systems, and methods are provided for assessing clot activity in blood under various conditions in vitro. The apparatus includes a plurality of test receptacles that receive the blood, at least one flow generating mechanism in communication with the test receptacles, and a clot detector configured to analyze an amount of clot formation that occurs within the blood in each receptacle. Blood contacting surfaces of a first subset of the test receptacles are coated with a first surface substrate and blood contacting surfaces of a second subset of the test receptacles are coated with a different second surface substrate. The flow generating mechanism is configured to generate a first blood flow rate through a third subset of the test receptacles and to generate a different second blood flow rate through a fourth subset of the test receptacles.

Claims (50)

1. A system for determining one or more thrombotic conditions of a patient, comprising:

at least one memory that stores computer-executable instructions; and

at least one processor configured to access the at least one memory, wherein the at least one processor is configured to execute the computer-executable instructions to:

receive a plurality of patient data points from a device which exposes a sample of the patient's blood to multiple exposure conditions in vitro, each patient data point comprising an amount of clot formation and one or more exposure conditions, wherein the one or more exposure conditions are selected through a quasi-random process that comprises a Sobol sequence;

create a virtual multi-dimensional representation of the plurality of patient data points; and

determine, based at least in part on the virtual multi-dimensional representation, one or more thrombotic conditions of the patient,

wherein the exposure conditions comprise blood contacting surface substrate, chemical agent addition, and blood flow rate.

2. The system of claim 1 , wherein the at least one processor is further configured to execute the computer-executable instructions to:

receive a plurality of predictive data points, each predictive data point comprising a blood outcome and one or more exposure conditions;

create a virtual multi-dimensional representation of the plurality of predictive data points; and

determine, based at least in part on the virtual multi-dimensional representation of the plurality of predictive data points and the one or more thrombotic conditions of the patient, an optimal thrombotic therapy.

3. The system of claim 1 , further comprising the device which exposes a sample of the patient's blood to multiple exposure conditions in vitro, wherein the device comprises:

a plurality of test receptacles adapted to receive a sample of blood, wherein blood contacting surfaces of a first subset of the plurality of test receptacles are coated with a first surface substrate, and blood contacting surfaces of a second subset of the plurality of test receptacles are coated with a second surface substrate which is different from the first surface substrate;

at least one flow generating mechanism in fluid communication with the plurality of test receptacles, wherein the at least one flow generating mechanism is configured to generate a first blood flow rate through a third subset of the plurality of test receptacles and a second blood flow rate which is different from the first blood flow rate through a fourth subset of the plurality of test receptacles; and

a clot detector configured to analyze an amount of clot formation, if any, that occurs within the sample of blood in each of the test receptacles.

4. The system of claim 3 , wherein the device further comprises one or more blood chambers in fluid communication with the plurality of test receptacles, each blood chamber configured to introduce a chemical agent into the sample of blood therein.

5. The system of claim 3 , wherein the at least one flow generating mechanism or at least one of the test receptacles is configured to introduce a chemical agent into the sample of blood therein.

6. The system of claim 3 , wherein the at least one flow generating mechanism comprises a volume displacement device.

7. The system of claim 6 , wherein:

the volume displacement device comprises syringe pumps, each syringe pump containing a piston having a volume, and

the blood flow rates are dependent upon the volumes of the pistons or upon rates of actuation of the syringe pumps.

8. The system of claim 6 , wherein:

the volume displacement device comprises deformable chambers, each deformable chamber having a volume, and

the blood flow rates are dependent upon the volumes of the deformable chambers or upon rates of compression of the deformable chambers.

9. The system of claim 6 , wherein the volume displacement device comprises a pump operable to generate (i) a positive pressure which is effective to push blood through or into the test receptacles, or (ii) a negative pressure which is effective to pull blood through or into the test receptacles.

10. A system for determining one or more thrombotic conditions of a patient, comprising:

at least one memory that stores computer-executable instructions; and

at least one processor configured to access the at least one memory, wherein the at least one processor is configured to execute the computer-executable instructions to:

receive a plurality of patient data points from a device which exposes a sample of the patient's blood to multiple exposure conditions in vitro, each patient data point comprising an amount of clot formation and one or more exposure conditions;

create a virtual multi-dimensional representation of the plurality of patient data points; and

determine, based at least in part on the virtual multi-dimensional representation, one or more thrombotic conditions of the patient,

wherein the exposure conditions comprise blood contacting surface substrate, chemical agent addition, and blood flow rate.

11. The system of claim 10 , wherein the at least one processor is further configured to execute the computer-executable instructions to:

receive a plurality of predictive data points, each predictive data point comprising a blood outcome and one or more exposure conditions;

create a virtual multi-dimensional representation of the plurality of predictive data points; and

determine, based at least in part on the virtual multi-dimensional representation of the plurality of predictive data points and the one or more thrombotic conditions of the patient, an optimal thrombotic therapy.

12. The system of claim 10 , further comprising the device which exposes a sample of the patient's blood to multiple exposure conditions in vitro, wherein the device comprises:

a plurality of test receptacles adapted to receive a sample of blood, wherein blood contacting surfaces of a first subset of the plurality of test receptacles are coated with a first surface substrate, and blood contacting surfaces of a second subset of the plurality of test receptacles are coated with a second surface substrate which is different from the first surface substrate;

at least one flow generating mechanism in fluid communication with the plurality of test receptacles, wherein the at least one flow generating mechanism is configured to generate a first blood flow rate through a third subset of the plurality of test receptacles and a second blood flow rate which is different from the first blood flow rate through a fourth subset of the plurality of test receptacles; and

a clot detector configured to analyze an amount of clot formation, if any, that occurs within the sample of blood in each of the test receptacles.

13. The system of claim 12 , wherein the device further comprises one or more blood chambers in fluid communication with the plurality of test receptacles, each blood chamber configured to introduce a chemical agent into the sample of blood therein.

14. The system of claim 12 , wherein the at least one flow generating mechanism or at least one of the test receptacles is configured to introduce a chemical agent into the sample of blood therein.

15. The system of claim 12 , wherein the at least one flow generating mechanism comprises a volume displacement device.

16. The system of claim 15 , wherein:

the volume displacement device comprises syringe pumps, each syringe pump containing a piston having a volume, and

the blood flow rates are dependent upon the volumes of the pistons or upon rates of actuation of the syringe pumps.

17. The system of claim 15 , wherein:

the volume displacement device comprises deformable chambers, each deformable chamber having a volume, and

the blood flow rates are dependent upon the volumes of the deformable chambers or upon rates of compression of the deformable chambers.

18. The system of claim 15 , wherein the volume displacement device comprises a pump operable to generate (i) a positive pressure which is effective to push blood through or into the test receptacles, or (ii) a negative pressure which is effective to pull blood through or into the test receptacles.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 30, 2019
From: KOLANDAIVELU, KUMARAN
To: MASSACHUSETTS INSTITUTE OF TECHNOLOGY; THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
Reel/Frame 049035/0795 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 23, 2019
From: EDELMAN, ELAZER R.
To: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Reel/Frame 048964/0397 →
Continuity (3)
Continuation PCTUS2012063613 · Nov 5, 2012
Provisional Application 61555691 · Nov 4, 2011
Related Publication 20140236494A1 · Aug 21, 2014